Page last updated: 2024-10-24

carbazilquinone and Carcinoma, Bronchogenic

carbazilquinone has been researched along with Carcinoma, Bronchogenic in 1 studies

Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.

Carcinoma, Bronchogenic: Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishikawa, S1
Hayashi, K1
Ree, T1
Saotome, K1
Yanai, N1
Iriki, A1
Kimura, S1
Hirata, M1
Nishiyama, Y1
Kawamura, M1

Other Studies

1 other study available for carbazilquinone and Carcinoma, Bronchogenic

ArticleYear
[Long-term results of the pulmonary resection with and without combined antineoplastic agents for primary bronchogenic carcinoma].
    Kyobu geka. The Japanese journal of thoracic surgery, 1985, Volume: 38, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Carbazilquinone; Carcinoma, Bron

1985